Brahmi(Bacopa monnieri), an Ayurvedic herb has primarily been used to enhance cognitive ability, memory and learning skills. We present a case study of schizophrenia in which add-on Brahmi extracts 500 mg/day for a period of one month resulted in reduction in psychopathology without any treatment-emergent adverse effect. Although preliminary, our case study suggests therapeutic efficacy of add-on Brahmi in schizophrenia, thus opening up a new dimension of its role in alternative medicines.
|Number of pages||3|
|Journal||Journal of Ayurveda and Integrative Medicine|
|Publication status||Published - 01-01-2012|
All Science Journal Classification (ASJC) codes
- Drug Discovery
- Complementary and alternative medicine